In this study, we investigated the in vivo role of adiponectin, an adipocytokine, on the development of atherosclerosis in rabbits mainly using adenovirus expressing adiponectin gene (Ad-APN) and intravascular ultrasonography. Serum adiponectin concentrations in rabbits after Ad-APN local transfer to abdominal aortas increased about nine times as much as those before transfer (P!0 . 01), about ten times as much as the levels of endogenous adiponectin in adenovirus expressing b-galactosidase gene (Ad-bgal) treated rabbits (P!0 . 01), and about four times as much as those in the aorta of non-injured rabbits on a normal cholesterol diet (P!0 . 01). Ultrasonography revealed a significantly reduced atherosclerotic plaque area in abdominal aortas of rabbits infected through intima with Ad-APN, by 35 . 2% compared with the area before treatment (P!0 . 01), and by 35 . 8% compared with that in Ad-bgal-treated rabbits (P!0 . 01). In rabbits infected through adventitia, Ad-APN treatment reduced plaque area by 28 . 9% as compared with the area before treatment (P!0 . 01) and 25 . 6% compared with that in Ad-bgal-treated rabbits (P!0 . 01). Adiponectin significantly suppressed the mRNA expression of vascular cell adhesion molecule-1 (VCAM-1) by 18 . 5% through intima transfer (P!0 . 05) and 26 . 9% through adventitia transfer (P!0 . 01), and intercellular adhesion molecule-1 (ICAM-1) by 40 . 7% through intima transfer (P!0 . 01), and 30 . 7% through adventitia transfer (P!0 . 01). However, adiponectin had no effect on the expression of types I and III collagen. These results suggest that local adiponectin treatment suppresses the development of atherosclerosis in vivo in part by attenuating the expression of VCAM-1 and ICAM-1 in vascular walls.
Introduction
Secreted by adipocytes, adiponectin is a collagen-like protein with significant roles in regulating the metabolism of glucose and fatty acids. Low plasma adiponectin levels are associated with insulin resistance and risk of type 2 diabetes (Spranger et al. 2003) . Adiponectin reduces the size of atherosclerotic lesions and inhibits neointimal thickening and proliferation of vascular smooth muscle cells in injured arteries and suppresses the expression of VCAMs (Ouchi et al. 1999) . Thus, adiponectin plays significant roles in preventing atherosclerosis.
The vascular adventitia is defined as the outermost connective tissue of vessels. Recently, the adventitia was increasingly considered a highly active segment of vascular tissue that contributes to a variety of disease pathologies, including atherosclerosis and restenosis (Shi et al. 1996 , 1997 , Houtkamp et al. 2001 , Sartore et al. 2001 . However, no data exist concerning the role of adiponectin in atherosclerosis development through the adventitia pathway. Since blood vessels are surrounded by much adipose tissue, could adiponectin play a protective role against atherosclerosis through paracrine pathways through adventitia? With these considerations in mind, the present study was designed to investigate the effects and mechanism of adiponectin on the development of atherosclerosis in New Zealand rabbits by local treatment using transfer of adenovirus expressing the full-length adiponectin gene to abdominal aortas and intravascular ultrasonography.
Materials and Methods

Animals and diet
Three-month-old male New Zealand rabbits weighing z1 . 5-2 . 0 kg and, standard and high-cholesterol diets were purchased from the Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Science (Shandong, China). The high-cholesterol diet was 1% cholesterol added to the standard diet. Each rabbit was fed 150 g/day, providing a daily intake of 1 . 5 g cholesterol.
The rabbits were allowed free access to water and were housed one rabbit per cage in a temperature-controlled environment. The Experimental Animal Management and Use Committee at Shandong University approved all animal use protocols.
Extraction of RNA
To clone the gene fragments, cervical back fat (brown fat) was obtained from 3-month-old male rabbits freely consuming a standard diet. The rabbits were given i.v. injections of anesthetic (3% pentobarbital sodium) at 30 mg/kg body weight. The s.c. adipose tissue was removed from the dorsal depot located over the cervical spine, rinsed with saline, then stored at K80 8C until RNA extraction. Total RNA was extracted from adipocytes or blood vessels with Trizol reagent (Invitrogen) following the manufacturer's instruction. Briefly, 100 mg adipose tissue or 1 cm abdominal aorta was cut and homogenized, and then 1 ml Trizol was added. The samples were then extracted with trichlormethane and precipitated with isopropyl alcohol. After ablution with 75% alcohol, the total RNAwas dissolved in 20 ml DEPC-H 2 O (diethylpyrocarbonate treated water) and quantified by spectrophotometry (Eppendorf BioPhotometer, Hamburg, Germany) at 260 nm/280 nm and stored at K70 8C.
Cloning of the rabbit adiponectin gene fragments
For cloning the adiponectin gene using RT-PCR, total RNA was denatured by heating at 75 8C for 5 min, then chilled on ice. Moloney murine leukemia virus (M-MLV) reverse transcriptase (Invitrogen), oligo (dT), dNTP, and H 2 O were added for a total volume of 20 ml. The reaction was incubated at 37 8C for 60 min, and then heated to 95 8C for 5 min, thus inactivating the reverse transcriptase and denaturing the template cDNA complexes.
Degenerative primers were designed from highly conserved regions of mouse and human adiponectin sequences and used to amplify adiponectin cDNA (forward primer, 5 0 -ACACCTCCAGGGCTCAGGATGCT-3 0 ; reverse primer, 5 0 -TCAGTTGGTATCATGG TAGAGAAG-3 0 ). The transcribed DNA was amplified by PCR for 35 cycles with DNA polymerase (Promega) is as follows: denaturation at 94 8C for 30 s (3 min in the first cycle), annealing at 55 8C for 30 s, and extension at 72 8C for 2 min (5 min in the last cycle). The PCR product was separated and purified with the EZNA Gel Extraction Kit (OMEGA Bio-tek Inc., Doraville, GA, USA) according to the manufacturer's protocol, and then sequenced (Invitrogen). The PCR product was cloned into a pGEM-T Vector System I (Promega) and named pGEM-T-APN.
Recombinant adenovirus
Primers were designed to clone the adiponectin gene fragment from pGEM-T-APN by the use of the KOD-Plus DNA Polymerase kit (TOYOBO Co. Ltd, Osaka, Japan; forward primer, 5 0 -CGGAATTCACACCTCCAGGGCT CAGGATGCT-3 0 ; reverse primer, 5 0 -ACGCGTCGACT CAGTTGGTATCATGGTAGAGAAG-3 0 ). A 771-bp fragment was extracted with use of QIAquick Gel Extraction kit (OMEGA Bio-tek Inc.) and digested with restriction enzymes (EcoRI and SalI) (New England Biolabs, Beverly, MA, USA). The product was ligated with PSU-CMV: a shuttle plasmid (pSU) containing cytomegalovirus (CMV) promoter vehicle (Sangon Biological Engineering & Technology and Service Co. Ltd, Shanghai, China) and transformed into Escherichia coli competent cells (Sangon). Plasmid DNA extracted from positive clones was cut with restriction enzymes, co-transferred with plasmid Pbhge3, including the right arm of type 5 adenovirus, to 293 cells (Microbix Biosystems Inc., Toronto, Ontario, Canada) and then purified by CsCl gradient centrifugation. The final product, named adiponectin-producing adenovirus (Ad-APN), was a tumor-specific non-proliferation adenovirus expressing adiponectin gene.
Protein expression in Pichia pastoris
Expression and purification of the protein were carried out with a pGAPZ a Pichia Expression Kit (Invitrogen) following the manufacturer's instruction. Briefly, cDNA containing the coding region of mature rabbit adiponectin was amplified by PCR (sense primer: 5 0 -GAATTCATGCTGTTGCTG CAAGCTGT-3 0 ; antisense primer: 5 0 -GCGGCCGCGTT GGTATCATGGTAGAG-3 0 ) (containing EcoRI and NotI sites), then inserted into the pGEM-T vector by T/A cloning strategy, leading to a subcloning vector pGEM/APN (containing adiponectin gene). By sequencing, the pGE-M/APN was confirmed to contain adiponectin gene, which was then inserted between the EcoRI and NotI sites of pGAPZ a (containing an amino-terminal His-tag) leading to pGAPZ a -APN. The pGAPZ a -APN was transformed into E. coli DH5a. E. coli DH5a strains were obtained from our laboratory and the restrictive enzymes were purchased from New England Biolabs.
After the above transformation, plate transformation was mixed onto low salt Luria-Bertain (LB) plates (1% tryptone, 0 . 5% yeast extract, 0 . 5% NaCl) with 25 mg/ml Zeocin (Invitrogen) and Zeocin-resistant colonies were selected. Zeocin-resistant transformants were inoculated into 2 ml low salt LB medium with 25 mg/ml Zeocin, grown overnight at 37 8C with shaking. The pGAPZ a -APN, linearized by cleaving with Bln I (New England Biolabs), was transformed into the GS115 yeast (obtained from our laboratory) by electroporation (Bio-Rad Laboratories). The transformants were plated on YPDS (1% yeast extract, 2% peptone, 2% dextrose, 1 M sorbitol, 2% agar) containing Zeocin (100 mg/ml) for positive selection. The recombinant yeasts were cultured in YPD medium (1% yeast extract, 2% peptone, 2% glucose) and grown in flasks at 30 8C with shaking (250-300 r.p.m.) overnight. The supernatant was transferred to a separate tube and stored at K80 8C until ready to assay. The culture media used in this study were purchased from Oxoid Ltd, Basingstoke, Hants, UK.
Western blot analyses
Sample proteins were separated by SDS-PAGE on 14% polyacrylamide gels and then transferred to nitrocellulose membrane. Following blocking with 5% non-fat milk, the blots were incubated with anti-His tag mouse monoclonal antibody (1:1000 dilution, Applygen Technologies Inc., Beijing, China) and rabbit adiponectin polyclonal antibody (1:100 dilution, Boster, Wuhan, Hubei, China) at 4 8C overnight. After overnight incubation, the blots were incubated with secondary antibody conjugated to horseradish peroxidase (1:2000 dilution, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and then visualized with enhanced chemiluminescence.
Construction of atherosclerotic rabbit models
We created the atherosclerotic model as described (Chen et al. 2004) . Briefly, a balloon catheter was inserted into the abdominal aorta of rabbits (nZ70) through the right femoral artery, and the aorta was injured by engorged balloons. Surviving rabbits were randomly divided into the following four groups: 1) Ad-APN transfer through intima (nZ18), 2) adenovirus expressing b-galactosidase gene (Ad-bgal) transfer through intima (nZ12), 3) Ad-APN transfer through adventitia (nZ18) and 4) Ad-bgal transfer through adventitia (nZ12), and received high-cholesterol diet for 3 months.
Intravascular ultrasonography procedure
Rabbits were anesthetized intravenously with 3% pentobarbital sodium at 30 mg/kg body weight. The left femoral artery was dissected and punctured. A detecting head for intravascular ultrasonography (Galaxy, Boston Scientific SciMed, Natick, MA, USA) was set at the distal end of the thoracic aorta and dragged back slowly along a guide wire (0 . 5 mm/s). Abdominal images were recorded.
Transfer of adenovirus
After ultrasonography, transfer of Ad-APN or Ad-bgal (Sangon) (6!10 9 pfu/ml, 0 . 5 ml for each rabbit) to abdominal aortic intima was as follows. The abdominal cavity was opened and the abdominal aorta dissociated. A locus from the renal artery gap extending downward 3 cm was chosen to transfer the adenovirus. First, blood supply was temporarily blocked from the two ends of the transfer position, and then Ad-APN or Ad-bgal was injected into the lumen of the vessel at the transfer position. Blood flow was recovered after 20 min.
The method for adventitia transfer was as follows. The abdominal aorta was isolated from the surrounding tissue, and then a polyethylene tube (3 cm long; inner diameter, 6 mm; outer diameter, 8 mm) was cut longitudinally to open the tube which was placed around the artery. The procedures for cuff placement were as described (Hisrosumi et al. 1987 , Yamasaki et al. 2003 with some modification. Ad-APN or Ad-bgal (6!10 9 pfu/ml, 0 . 5 ml for each rabbit) was injected into a space between the cuff and the artery and the two ends of the cuff were stuffed with gelatin sponge. Cuff and gelatin sponge were removed after 20 min.
Collection of samples and plasma data analyses
On day 14 after gene transfer, surviving rabbits (nZ50) were anesthetized and underwent repeat ultrasonography, then abdominal aortas were harvested. Blood samples were collected and the level of total cholesterol, high-density lipoprotein cholesterol, triglyceride, and low-density lipoprotein cholesterol were determined by use of an automatic biochemistry analyzer (Hitachi).
ELISA assay
Adiponectin levels in rabbit serum and in the supernatant of cultured Pichia pastoris were quantitatively determined through immunoassays. A kit consisting of rat anti-human adiponectin enzyme (BPB Biomedicals, Inc., Franklin, CA, USA) was applied and the measurements were performed following the manufacturer's instructions.
Histochemical analyses
Frozen cross-sections (8 mm thick) of abdominal aortas embedded in optimal cutting temperature compound after overnight fixation in 10% formalin were mounted on slides. For the analyses of plaque size, the three sections (100 mm apart) from each rabbit on the 14th day after adenovirus transfer were stained with Oil Red O (ORO). The lesion size was quantified with the use of Image-Pro Plus 5.0 software (MediaCybernetics, Silver Spring, MD, USA) and the mean values were determined. For immunohistochemical analyses, paraffin-imbedded cross-sections (5 mm thick) were incubated with either rabbit adiponectin polyclonal antibody (Boster), mouse vascular adhesion molecule-1 (VCAM-1) monoclonal antibody (Santa Cruz), mouse intercellular adhesion molecule-1 (ICAM-1) monoclonal antibody (Santa Cruz), mouse collagen I (Abcam, Cambridge, MA, USA), or mouse collagen III (Calbiochem, Darmstadt, Germany) monoclonal antibody.
Real-time PCR analyses
VCAM-1, ICAM-1, and type I and III collagen cDNA were cloned with total RNA of abdominal aortas by RT-PCR. The relative quantitation of target gene expression was determined by use of LightCycler (Roche) following the manufacturer's protocol. To quantify the expression of VCAM-1 and ICAM-1, real-time PCR involving the use of the SYBR Green kit (TaKaRa, Dalian, Liaoning, China) was carried out according to the manufacturer's instructions. For quantification of type I and III collagen level, TaqMan hydrolysis probes were utilized (sense and antisense primers are shown in Table 1 ). The conditions for real-time PCR were as follows: denaturation at 95 8C for 30 s, then the 40 cycles at 95 8C 0 s, annealing for 10 s, and extension at 72 8C for 10 s. The annealing temperatures for the control glyceraldehyde-3-phosphate dehydrogenase (GAPDH), VCAM-1, ICAM-1, type I and III collagen were 60, 60, 58, 58, and 58 8C respectively. The expression ratio of target gene to GAPDH represents the mRNA level. Data were analyzed with the use of LightCycler 4.0 (Roche).
Statistical analyses
Data were analyzed using an ANOVA procedure. A value of P!0 . 05 was considered statistically significant. Data are presented as meansGS.E.M. SPSS for Windows Version 13.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis.
Results
Cloning of rabbit adiponectin
To investigate whether rabbit adiponectin gene might have the same function as that in humans and mice, we used RT-PCR and adipocytes RNA to clone rabbit adiponectin with translation start code (atg) and stop code (tga) (GenBank DQ334867). The open reading frame for rabbit adiponectin is 735 bp long, and when translated, yields a protein of 244 amino acids. Rabbit adiponectin is highly homologous to that of humans (86 . 4%; GenBank NM004797) and mice (81 . 5%; GenBank NM009605), with 85 . 7 and 85 . 3% identity at the amino acid level respectively.
Serum adiponectin and expression of adiponectin in vitro
Serum samples were collected from rabbits before aorta injury, before and after adenovirus transfer, and subjected to ELEISA assay. Serum adiponectin concentrations in rabbits after Ad-APN intima and adventitia transfer increased about nine times as much as those before transfer (intima: 9 . 17G 0 . 61 vs 1 . 02G0 . 06 mg/ml, P!0 . 01; adventitia: 9 . 27G0 . 23 vs 1 . 02G0 . 06 mg/ml, P!0 . 01). After transfer, the serum adiponectin concentrations elevated to a level about ten times higher than the level of endogenous adiponectin in Ad-bgaltreated rabbits (intima: 9 . 17G0 . 61 vs 0 . 92G0 . 05 mg/ml, P!0 . 01; adventitia: 9 . 27G0 . 23 vs 0 . 90G0 . 05 mg/ml, P!0 . 01), and about four times higher than those in the aorta of non-injured rabbits on a normal cholesterol diet (2 . 45G0 . 17 mg/ml, P!0 . 01) (Fig. 1) .
As shown in Fig. 2 , western blotting with the anti-His tag monoclonal antibody or adiponectin polyclonal antibody indicated a single predominant band at approximately 42 kDa (containing 9 . 3 kDa a-factor signal peptide and 2 . 5 kDa C-terminal His-tag). Adiponectin level in the supernatant of cultured Pichia pastoris was 0 . 29G0 . 02 mg/ml.
Lipid characteristics of adenovirus-infected rabbits
No significant difference was observed between cholesterol and triglyceride levels in Ad-APN-and Ad-bgal-infected rabbits (Table 2) .
Atherosclerosis was reduced by regional transfer of Ad-APN
Ultrasonography revealed a significantly reduced atherosclerotic plaque area, in abdominal aortas of rabbits infected through intima with Ad-APN, by 35 . 2% compared with the area before treatment (3 . 98G0 . 32 In rabbits with Ad-APN infection through intima, the atherosclerotic plaque area as seen on ORO staining (Fig. 4 as compared with those in Ad-bgal-treated rabbits. In rabbits infected through adventitia, the plaque area and maximal thickness of plaque were reduced by a similar significant level.
Adiponectin inhibits mRNA expression of VCAM-1 and ICAM-1
Immunohistochemical analyses revealed that adenovirusderived rabbit adiponectin abundantly adhered to cells in the atherosclerotic plaque of rabbits through intima transfer. In rabbits treated through adventitia, adiponectin adhered to cells among adventitia (Fig. 5A) .
When compared with Ad-bgal treatment, infection with Ad-APN through intima showed significantly suppressed mRNA expression of VCAM-1 (by 18 . 5%, 20 with Ad-bgal-treated rabbits. However, rabbits infected through intima or adventitia showed no significant difference in atherosclerotic plaque area, LAS, plaque maximal thickness or mRNA level of VCAM-1 and ICAM-1 in the abdominal aorta (Fig. 5B) .
As well, Ad-APN-and Ad-bgal-treated rabbits did not differ in expression of type I and III collagen, regardless of infection through intima or adventitia.
Discussion
Traditionally, adipose has been considered a simple energy storage tissue, but mounting evidence suggests that it can produce and secrete many bioactive substances, collectively referred to as adipocytokines. One of these, adiponectin, has significant roles in regulating the metabolism of glucose and fatty acids, and in protecting against atherosclerosis. Adiponectin is a collagen-like protein, whose gene is located on human chromosome 3q27 and is named as apM 1 gene. The full-length of apM 1 gene is 17 kbp, which includes 3 exons and 2 introns. The full-length of apM 1 mRNA is 4517 bp (Scherer et al. 1995 , Hu et al. 1996 , Maeda et al. 1996 .
In the present study, we report for the first time the sequence of rabbit adiponectin and provide the amino acid sequence of the deduced protein. Sequence analyses showed that both the coding region and the amino acid sequence share high homology with adiponectin of humans and mice. The anti-His tag monoclonal antibody and adiponectin polyclonal antibody detected a single predominant protein Figure 1 Serum adiponectin concentrations in rabbits. 1, Aorta non-injured rabbits on normal cholesterol diet; 2, aorta injured rabbits on high-cholesterol diet before adenovirus transfer; 3, after transfer Ad-bgal through intima; 4, after transfer Ad-APN through intima; 5, after transfer Ad-bgal through adventitia; 6, After transfer Ad-APN through adventitia. The symbol * indicates significant difference (P!0 . 01) vs serum adiponectin concentrations in aorta non-injured rabbits on normal cholesterol diet; † compared with rabbits before adenovirus transfer; and ‡ compared with rabbits after Ad-bgal transfer. The values are meansGS.E.M. of z30 kDa (subtracting 9 . 3 kDa a-factor signal peptide and 2 . 5 kDa C-terminal His-tag) in the supernatant of cultured Pichia pastoris. The adiponectin protein is similar in size to the single protein detected in human serum by the monoclonal antibody (Yoda-Murakami et al. 2001) . The results suggest a similar function of adiponectin protein in rabbits as in other species in improving insulin resistance (Kubota et al. 2002 , stimulating fatty-acid oxidation , and preventing vascular stenosis . Okamoto et al. (2002) reported that injection of Ad-APN into the tail vein of apolipoprotein E-deficient mice inhibited lesion formation by 30%. In another study, low plasma adiponectin levels were found to be associated with progression of subclinical coronary atherosclerosis in people with type 1 diabetes and in non-diabetes subjects independently of other cardiovascular risk factors (Maahs et al. 2005) .
For further investigation of the protective role of adiponectin in atherosclerosis, we constructed a replicationdefective adenovirus, expressing the rabbit adiponectin gene (Ad-APN) and transferred the adenovirus to abdominal aortas of an atherosclerotic rabbit model. The serum adiponectin concentrations in rabbits after 3 months high-cholesterol diet significantly decreased about two times compared with those in aorta non-injured rabbits on a normal cholesterol diet. After adenovirus transfer, the serum adiponectin concentrations of Ad-APN-treated rabbits notably increased and the atherosclerotic area was significantly reduced as seen on ORO staining and on ultrasonography. Thus, adiponectin plays a significantly protective role against atherosclerosis in rabbits.
The connective tissue adventitia in the aorta protects, supports, and nourishes the blood vessels. However, it has been found to secrete many vasoactive substances in a paracrine way to regulate the relaxation and construction of blood vessels and to influence the structure of blood vessels. Nitrogen oxide (NO) is an important vasoactive substance that could be synthesized by adventitial myofibroblast cells (Kleschyov et al. 2000) . Zhang et al. (1999) reported that adventitia was a source of inducible nitric oxide synthase (NOS) in the rat aorta. The mRNA expression and protein production of iNOS of adventitia increased following cytokine stimulation, thus increasing NO production. As reported in other studies, NO inhibits the proliferation of vascular smooth muscle cells to improve vascular stenosis (Scott-Burden & Vanhoutte 1994) . In the present study, we demonstrated that the atherosclerotic plaque area of rabbits treated with adenovirus expressing adiponectin through adventitia was significantly reduced compared with that before treatment and with rabbits treated with Ad-bgal. But no significant difference was observed between two groups treated with Ad-APN through intima or adventitia transfer.
Although the mechanism for the protective contribution against atherosclerosis of adiponectin is unclear at present, the cytokine could inhibit TNF-a-induced expression of adhesive molecules by blocking nuclear factor-kB, and it could inhibit proliferation of smooth muscle cells induced by growth factors by inhibiting mitogen-activated protein pathways (Lappas et al. 2005) . Adiponectin has been shown to reduce atherosclerosis through attenuating endothelial inflammatory response and macrophage-to-foam cell transformation . Meanwhile, adiponectin suppresses the expression of NF-kB-inducible genes, including VCAM-1, in endothelial cells and class A scavenger receptor expression in monocyte-derived macrophages (Ouchi et al. 2001 , Lappas et al. 2005 . In the present study, we investigated the expression of VCAM-1 and ICAM-1 in abdominal aortas of atherosclerotic rabbits treated with Ad-APN through intima and adventitia. Ad-APN treatment inhibited the expression of VCAM-1 and ICAM-1 in vivo but did not significantly affect the synthesis of type I and III collagen. The findings suggest that adiponectin improves atherosclerosis in part through inhibition of the expression of VCAM-1 and ICAM-1 in the vascular wall but not through regulating type I and III collagen synthesis.
In summary, we show that local Ad-APN treatment through intima or adventitia reduces atherosclerotic plaque area, although the exact mechanism needs further investigation. Our studies have helped to elucidate the protective mechanism of adiponectin in atherosclerosis.
